Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości ETFBNQ3LV
1682.80+27.80(+1.68%)BETA ETF NASDAQ-100 3x
GPW - ETF
Biznesradar bez reklam? Sprawdź BR Plus
Introduction Tactile Systems Technology, Inc. (NASDAQ: TCMD) reported second-quarter 2026 results that pointed to a cleaner operating picture than the...
The post Tactile Systems Technology (TCMD) Q2 2026 Results Show Lymphedema Growth Is Driving the Profitability Story first appeared on Alphastreet.
Introduction iHeartMedia, Inc. (NASDAQ: IHRT) reported second-quarter 2026 results that again showed the split at the center of its equity...
The post iHeartMedia (IHRT) Q2 2026 Results Show Digital Audio Growth Is Still Fighting a Heavy Balance-Sheet Burden first appeared on Alphastreet.
Introduction Neuronetics, Inc. (NASDAQ: STIM) reported second-quarter 2026 results on August 11, 2026 that showed a clearer split between its...
The post Neuronetics (STIM) Q2 2026 Results Show Greenbrook Growth Is Outrunning the Legacy NeuroStar Business first appeared on Alphastreet.
Why Evolv’s Latest Quarter Keeps Deployment Growth, Product Credibility, and Cash Discipline in Focus Evolv Technologies Holdings, Inc. (NASDAQ: EVLV)...
The post Evolv (EVLV) Q2 2026 Results Show Deployment Momentum and Recurring Revenue Growth Are Starting to Translate Into Profitability first appeared on Alphastreet.
Analog Devices, Inc. (NASDAQ: ADI) reported a sharp increase in revenues for the third quarter of fiscal 2026, driving adjusted...
The post Analog Devices (ADI) Q3 FY26 earnings beat estimates; revenue jump 40% first appeared on Alphastreet.
Analog Devices, Inc. (NASDAQ: ADI) reported a sharp increase in revenues for the third quarter of fiscal 2026, driving adjusted...
The post Analog Devices (ADI) Q3 FY26 earnings beat estiamtes; revenue jump 40% first appeared on Alphastreet.
Gaia, Inc. (NASDAQ: GAIA) reported its second-quarter results with a clear strategic message: management is willing to accept weaker near-term...
The post Gaia’s Direct-Member Pivot Is Pressuring Revenue Before the Cash Flow Test first appeared on Alphastreet.
Better-than-Expected Loss. Evogene Ltd. (NASDAQ: EVGN) reported a Q2 2026 loss of $0.14 per share, coming in 50.0% narrower than the $0.28 loss analysts ant...
The post Evogene Q2 2026: Loss Narrows 50.0% to -$0.14/Share, Revenue Down 35% first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
